Jianmei Pang
Publications by Year
Research Areas
Neuropeptides and Animal Physiology, Receptor Mechanisms and Signaling, Pharmacogenetics and Drug Metabolism, Diabetes Treatment and Management, Drug Transport and Resistance Mechanisms
Most-Cited Works
- → Studies on Cytochrome P-450-Mediated Bioactivation of Diclofenac in Rats and in Human Hepatocytes: Identification of Glutathione Conjugated Metabolites(1999)170 cited
- → Fluoroolefins as amide bond mimics in dipeptidyl peptidase IV inhibitors(2008)106 cited
- → Determination ofin vitro permeability of drug candidates through a Caco-2 cell monolayer by liquid chromatography/tandem mass spectrometry(2000)102 cited
- → Discovery of MK-5046, a Potent, Selective Bombesin Receptor Subtype-3 Agonist for the Treatment of Obesity(2010)65 cited
- → Discovery of MK-7725, A Potent, Selective Bombesin Receptor Subtype-3 Agonist for the Treatment of Obesity(2012)62 cited
- → Folate-conjugated hybrid SBA-15 particles for targeted anticancer drug delivery(2012)58 cited
- → Discovery of N-[Bis(4-methoxyphenyl)methyl]-4-hydroxy-2-(pyridazin-3-yl)pyrimidine-5-carboxamide (MK-8617), an Orally Active Pan-Inhibitor of Hypoxia-Inducible Factor Prolyl Hydroxylase 1–3 (HIF PHD1–3) for the Treatment of Anemia(2016)54 cited
- → A Microdose Cocktail to Evaluate Drug Interactions in Patients with Renal Impairment(2020)52 cited
- → Investigation on the Enzymatic Profile of Mulberry Alkaloids by Enzymatic Study and Molecular Docking(2019)46 cited
- → Discovery of Benzodiazepine Sulfonamide-Based Bombesin Receptor Subtype 3 Agonists and Their Unusual Chirality(2011)44 cited